Peter Radovich Mirum Pharmaceuticals, Inc. (MIRM) insider trading activity

Peter Radovich is PRESIDENT AND COO of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 12,111 shares of MIRM, which is worth approximately $526,344. The most recent transaction as insider was on Mar 04, 2025, when has been sold 14,850 shares (Common Stock) at a price of $45.66 per share, resulting in proceeds of $678,051. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.1K

58.26% 3M change

65.09% 12M change

Total Value Held $526,344

Peter Radovich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2025	SELL Open market or private sale	$678,051 $45.66 p/Share	14,850 Reduced 55.08%	12,111 Common Stock
Feb 03 2025	SELL Open market or private sale	$126,673 $48.22 p/Share	2,627 Reduced 8.88%	26,961 Common Stock
Jan 24 2025	SELL Open market or private sale	$152,241 $47.92 p/Share	3,177 Reduced 9.7%	29,588 Common Stock
Jan 23 2025	BUY Exercise of conversion of derivative security	-	5,750 Added 14.93%	32,765 Common Stock
Jan 07 2025	SELL Open market or private sale	$85,554 $42.82 p/Share	1,998 Reduced 6.89%	27,015 Common Stock
Mar 25 2024	SELL Open market or private sale	$111,017 $25.8 p/Share	4,303 Reduced 12.92%	29,013 Common Stock
Feb 02 2024	SELL Open market or private sale	$46,880 $26.19 p/Share	1,790 Reduced 4.91%	34,695 Common Stock
Jan 08 2024	SELL Open market or private sale	$39,466 $28.03 p/Share	1,408 Reduced 3.72%	36,485 Common Stock
Nov 10 2023	BUY Grant, award, or other acquisition	$4,859 $22.29 p/Share	218 Added 0.57%	37,893 Common Stock
Jul 03 2023	SELL Open market or private sale	$36,551 $25.65 p/Share	1,425 Reduced 3.64%	37,675 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	$16,378 $16.92 p/Share	968 Added 2.42%	39,100 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	14,440 Added 27.47%	38,132 Common Stock
Jan 09 2023	SELL Open market or private sale	$28,434 $20.62 p/Share	1,379 Reduced 3.97%	33,316 Common Stock
Nov 10 2022	BUY Grant, award, or other acquisition	$4,978 $17.05 p/Share	292 Added 1.22%	23,692 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	$15,863 $13.57 p/Share	1,169 Added 4.76%	23,400 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	10,000 Added 31.03%	22,231 Common Stock
Nov 10 2021	BUY Grant, award, or other acquisition	$12,952 $13.52 p/Share	958 Added 7.26%	12,231 Common Stock
Oct 01 2021	SELL Open market or private sale	$26,271 $19.26 p/Share	1,364 Reduced 10.79%	11,273 Common Stock
Sep 29 2021	BUY Grant, award, or other acquisition	-	8,125 Added 39.13%	12,637 Common Stock
May 10 2021	BUY Grant, award, or other acquisition	$14,708 $14.62 p/Share	1,006 Added 18.23%	4,512 Common Stock
Nov 10 2020	BUY Grant, award, or other acquisition	$13,147 $15.27 p/Share	861 Added 19.72%	3,506 Common Stock

Also insider at

RAIN

Rain Therapeutics Inc. Healthcare

Director

Peter Radovich

PRESIDENT AND COO

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Value

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM

Account